These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 27916907)

  • 1. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
    Cheng K; Hao M
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Inhibits Epithelial-to-Mesenchymal Transition of Keloid Fibroblasts via the HIF-1α/PKM2 Signaling Pathway.
    Lei R; Zhang S; Wang Y; Dai S; Sun J; Zhu C
    Int J Med Sci; 2019; 16(7):960-966. PubMed ID: 31341409
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress.
    Liu Y; Yuan X; Li W; Cao Q; Shu Y
    Int J Mol Med; 2016 Oct; 38(4):1235-42. PubMed ID: 27573422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SiRNA Targeting mTOR Effectively Prevents the Proliferation and Migration of Human Lens Epithelial Cells.
    Zhang C; Liu J; Jin N; Zhang G; Xi Y; Liu H
    PLoS One; 2016; 11(12):e0167349. PubMed ID: 27911920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
    Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chemosensitizing Role of Metformin in Anti-Cancer Therapy.
    Tang Z; Tang N; Jiang S; Bai Y; Guan C; Zhang W; Fan S; Huang Y; Lin H; Ying Y
    Anticancer Agents Med Chem; 2021; 21(8):949-962. PubMed ID: 32951587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells
    Tang JC; An R; Jiang YQ; Yang J
    Cancer Res Treat; 2017 Jul; 49(3):778-789. PubMed ID: 27857021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
    Tyszka-Czochara M; Lasota M; Majka M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
    Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.
    Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS
    J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
    Nakayama A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Int J Oncol; 2016 Nov; 49(5):1890-1898. PubMed ID: 27599468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of angiotensin II type-1 receptor inhibits high glucose-induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells via inactivation of mTOR/p70S6K signaling pathway.
    Gong Q; Hou F
    Biochem Biophys Res Commun; 2016 Jan; 469(2):183-8. PubMed ID: 26626074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells through the Inhibition of Akt/mTOR Pathway.
    Zhu FQ; Chen MJ; Zhu M; Zhao RS; Qiu W; Xu X; Liu H; Zhao HW; Yu RJ; Wu XF; Zhang K; Huang H
    Biol Pharm Bull; 2017 Jan; 40(1):17-24. PubMed ID: 27829579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway.
    Han B; Cui H; Kang L; Zhang X; Jin Z; Lu L; Fan Z
    Tumour Biol; 2015 Aug; 36(8):6295-304. PubMed ID: 25854169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrotic Effects of Hepatocyte Growth Factor on Endothelial-to-Mesenchymal Transition via Transforming Growth Factor-Beta1 (TGF-β1)/Smad and Akt/mTOR/P70S6K Signaling Pathways.
    Wang Z; Fei S; Suo C; Han Z; Tao J; Xu Z; Zhao C; Tan R; Gu M
    Ann Transplant; 2018 Jan; 23():1-10. PubMed ID: 29292365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.